New requirements for suppliers can cause a shortage of imported drugs in Russia

news

The Association of European Businesses (AEB) predicts the occurrence of interruptions with imported medicines in Russia because of the requirements that will soon be presented to suppliers during the introduction of the new system of labeling of medicines, they write "Izvestia".
By 2019, all suppliers must implement a drug labeling system using a new technology that requires manufacturers to make certain investments,which in AEB is estimated at several million dollars for one plant. The association fears that the new requirements will lead to interruptions in the supply of imported medicines.
Ivanov Glushkov, representative of the AEB, told Izvestia that the information system of the Federal Tax Service, to which importers need drugs to be connected within the framework of the project on drug labeling, requires a change in the accounting systems of all market entities. He stressed that the drug, which will not transfer information about the shipping price to the FTS system, can not be sold in Russia. To this end, factories that are not even registered in Russia, but produce medicines in Russian packaging, will have to transmit information to the system about the fact of dispatching a consignment of medicines, indicating the cost of each medication.
Now factories and distributors do not detail the cost of one package of the product when signing contracts, they indicated total sums in the framework of supply contracts. Glushkov stressed that manufacturers will have to change their internal management system to meet the new Russian standards.Foreign companies that deal with small supplies to Russia will not be able to afford it.
Currently, the AEB is preparing a letter to Deputy Prime Minister Arkady Dvorkovich with a request to postpone the introduction of mandatory labeling of medicines.

A source:

Remedium